4.6 Article

Reduced prostaglandin F-2 alpha release from blood mononuclear leukocytes after oral supplementation of omega 3 fatty acids: the OmegAD study

期刊

JOURNAL OF LIPID RESEARCH
卷 51, 期 5, 页码 1179-1185

出版社

ELSEVIER
DOI: 10.1194/jlr.M002667

关键词

DHA; EPA; LPS; Omega-3 fatty acid; PBMC; PGF; PHA; prostaglandin

资金

  1. Swedish Medical Research Council [19X05991, 71XS-13135]
  2. Swedish Association against Rheumatism
  3. Karolinska Institutet
  4. Huddinge University Hospital
  5. Funds of A Wiberg
  6. King Gustaf V: s 80-year
  7. Uggla
  8. N Svartz
  9. Vardal
  10. Swedish Cancer Society
  11. Cancer Society of Stockholm
  12. Swedish Alzheimer Foundation

向作者/读者索取更多资源

Omega-3 fatty acids, e. g., dokosahexaenoic acid (DHA) and eikosapentaenoic acid (EPA), ameliorate inflammatory reactions by various mechanisms, but the role of prostaglandins remains unclear. Our aim was to determine if dietary supplementation with a DHA-rich fish oil influenced the release of PGF(2 alpha) from peripheral blood mononuclear cells (PBMC). In the OmegAD study, 174 Alzheimer disease patients received either 1.7 g DHA plus 0.6 g EPA or a placebo daily for six months. PBMCs from the 21 ( 9 on fish oil and 12 on placebo) first-randomized patients were stimulated with either lipopolysaccharide (LPS) or phytohemagglutinin (PHA) before and after 6 months. Our results showed that plasma concentrations of DHA and EPA increased significantly at 6 months in the omega-3 group. PGF(2 alpha) release from LPS- ( but not from PHA-) stimulated PBMC was significantly diminished in this group; no change was noted in the placebo group. PGF(2 alpha) changes correlated inversely with changes in plasma DHA and EPA. Decreased IL-6 and IL-1(beta) levels correlated with decreased PGF(2 alpha) levels. The stimulus-specific PGF(2 alpha) release from PBMC after 6 months of oral supplementation with the DHA-rich fish oil might be one event related to reduced inflammatory reactions associated with omega-3 fatty acid intake.-Vedin, I., T. Cederholm, Y. Freund-Levi, H. Basun, E. Hjorth, G. F. Irving, M. Eriksdotter-Jonhagen, M. Schultzberg, L-O. Wahlund, and J. Palmblad. Reduced prostaglandin F-2 alpha release from blood mononuclear leukocytes after oral supplementation of omega 3 fatty acids: the OmegAD study. J. Lipid Res. 2010. 51: 1179-1185.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Dentistry, Oral Surgery & Medicine

Validating a model for medication-related dental outcomes in older people

Edwin C. K. Tan, Duangjai Lexomboon, Henrike Habel, Johan Fastbom, Maria Eriksdotter, Kristina Johnell, Gunilla Sandborgh-Englund

Summary: This study externally validated a model for medication-related dental outcomes in older adults with and without dementia using population-based data from Swedish national registers. The results showed that certain medication types were associated with tooth extraction and restorative procedures in both dementia and non-dementia cohorts, indicating consistent performance of the model across different groups.

ORAL DISEASES (2022)

Article Clinical Neurology

Characteristics of subjective cognitive decline associated with amyloid positivity

Olin Janssen, Willemijn J. Jansen, Stephanie J. B. Vos, Merce Boada, Lucilla Parnetti, Tomasz Gabryelewicz, Tormod Fladby, Jose Luis Molinuevo, Sylvia Villeneuve, Jakub Hort, Stephane Epelbaum, Alberto Lleo, Sebastiaan Engelborghs, Wiesje M. van der Flier, Susan Landau, Julius Popp, Anders Wallin, Philip Scheltens, Marcel Olde Rikkert, Peter J. Snyder, Chris Rowe, Gael Chetelat, Agustin Ruiz, Marta Marquie, Elena Chipi, Steffen Wolfsgruber, Michael Heneka, Henning Boecker, Oliver Peters, Jonas Jarholm, Lorena Rami, Adria Tort-Merino, Alexa Pichet Binette, Judes Poirier, Pedro Rosa-Neto, Jiri Cerman, Bruno Dubois, Marc Teichmann, Daniel Alcolea, Juan Fortea, M. Belen Sanchez-Saudinos, Jarith Ebenau, Cornelia Pocnet, Marie Eckerstrom, Louisa Thompson, Victor Villemagne, Rachel Buckley, Samantha Burnham, Marion Delarue, Yvonne Freund-Levi, Asa K. Wallin, Inez Ramakers, Magda Tsolaki, Hilkka Soininen, Harald Hampel, Luiza Spiru, Betty Tijms, Rik Ossenkoppele, Frans R. J. Verhey, Frank Jessen, Pieter Jelle Visser

Summary: In addition to age, setting, and APOE ε4 carriership, specific characteristics of subjective cognitive decline may aid in identifying individuals with amyloid positivity.

ALZHEIMERS & DEMENTIA (2022)

Article Biochemistry & Molecular Biology

Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation

Alexander Neumann, Fahri Kucukali, Isabelle Bos, Stephanie J. B. Vos, Sebastiaan Engelborghs, Tim De Pooter, Geert Joris, Peter De Rijk, Ellen De Roeck, Magda Tsolaki, Frans Verhey, Pablo Martinez-Lage, Mikel Tainta, Giovanni Frisoni, Oliver Blin, Jill Richardson, Regis Bordet, Philip Scheltens, Julius Popp, Gwendoline Peyratout, Peter Johannsen, Lutz Froelich, Rik Vandenberghe, Yvonne Freund-Levi, Johannes Streffer, Simon Lovestone, Cristina Legido-Quigley, Mara ten Kate, Frederik Barkhof, Mojca Strazisar, Henrik Zetterberg, Lars Bertram, Pieter Jelle Visser, Christine van Broeckhoven, Kristel Sleegers

Summary: In this study, rare variants in certain genes were found to be associated with Alzheimer's disease biomarkers. Four genes were associated with neuronal injury and inflammation, potentially increasing the risk of dementia by altering cytoskeleton structure and immune activity disinhibition. Two genes were associated with synaptic functioning, but had no consequential effect on AD development.

MOLECULAR PSYCHIATRY (2022)

Article Clinical Neurology

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

Willemijn J. Jansen, Olin Janssen, Betty M. Tijms, Stephanie J. B. Vos, Rik Ossenkoppele, Pieter Jelle Visser

Summary: This study aims to estimate the prevalence of amyloid abnormality in individuals with different cognitive statuses and examine the factors that may affect these estimates. The results show that CSF-based estimates using adjusted data-driven cutoffs were higher than PET-based estimates in individuals without dementia, suggesting that preclinical and prodromal AD may be more prevalent than previously estimated. This finding has important implications for clinical trial recruitment strategies and healthcare planning policies.

JAMA NEUROLOGY (2022)

Article Clinical Neurology

Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology

Aurore Delvenne, Johan Gobom, Betty Tijms, Isabelle Bos, Lianne M. Reus, Valerija Dobricic, Mara Ten Kate, Frans Verhey, Inez Ramakers, Philip Scheltens, Charlotte E. Teunissen, Rik Vandenberghe, Jolien Schaeverbeke, Silvy Gabel, Julius Popp, Gwendoline Peyratout, Pablo Martinez-Lage, Mikel Tainta, Magda Tsolaki, Yvonne Freund-Levi, Simon Lovestone, Johannes Streffer, Frederik Barkhof, Lars Bertram, Kaj Blennow, Henrik Zetterberg, Pieter Jelle Visser, Stephanie J. B. Vos

Summary: The pathophysiology of MCI-SNAP is distinct from that of MCI-AD, highlighting the need for different treatment approaches.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Dementia prevention: The potential long-term cost-effectiveness of the FINGER prevention program

Anders Wimo, Ron Handels, Riitta Antikainen, Maria Eriksdotter, Linus Jonsson, Martin Knapp, Jenni Kulmala, Tiina Laatikainen, Jenni Lehtisalo, Markku Peltonen, Anders Skoldunger, Hilkka Soininen, Alina Solomon, Timo Strandberg, Jaakko Tuomilehto, Tiia Ngandu, Miia Kivipelto

Summary: This study estimated the potential cost-effectiveness of the FINGER program in Finland. The results showed that the FINGER program could save costs and improve quality-adjusted life years, supporting its effectiveness in preventing cognitive impairment and disability.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Cholinergic white matter pathways along the Alzheimer's disease continuum

Milan Nemy, Martin Dyrba, Frederic Brosseron, Katharina Buerger, Peter Dechent, Laura Dobisch, Michael Ewers, Klaus Fliessbach, Wenzel Glanz, Doreen Goerss, Michael T. Heneka, Stefan Hetzer, Enise I. Incesoy, Daniel Janowitz, Ingo Kilimann, Christoph Laske, Franziska Maier, Matthias H. Munk, Robert Perneczky, Oliver Peters, Lukas Preis, Josef Priller, Boris-Stephan Rauchmann, Sandra Roeske, Nina Roy, Klaus Scheffler, Anja Schneider, Bjorn H. Schott, Annika Spottke, Eike J. Spruth, Michael Wagner, Jens Wiltfang, Renat Yakupov, Maria Eriksdotter, Eric Westman, Olga Stepankova, Lenka Vyslouzilova, Emrah Duezel, Frank Jessen, Stefan J. Teipel, Daniel Ferreira

Summary: Nemy et al. investigate cholinergic white matter projections along the Alzheimer's disease continuum, finding that alterations in these pathways are present in individuals with subjective cognitive decline. These alterations precede the more widespread changes seen in mild cognitive impairment and Alzheimer's disease dementia. The study highlights the potential of using cholinergic white matter pathways as markers for the early stages of Alzheimer's disease.
Review Geriatrics & Gerontology

Cognitive impairment in people with physical frailty using the phenotype model: A systematic review and meta analysis

Ali Vahedi, Maria Eriksdotter, Hege Ihle-Hansen, Torgeir Bruun Wyller, Anne Rita Oksengard, Brynjar Fure

Summary: This study conducted a systematic review and meta-analysis to examine the relationship between cognitive functioning and phenotypic frailty status. The results showed that individuals in a frail state had poorer cognitive functioning, particularly in the domain of memory. These findings highlight the importance of incorporating cognitive function in assessments of frailty.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2022)

Article Urology & Nephrology

Association between cholinesterase inhibitors and kidney function decline in patients with Alzheimer's dementia

Hong Xu, Sara Garcia-Ptacek, Annette Bruchfeld, Edouard L. Fu, Taher Darreh Shori, Bengt Lindholm, Maria Eriksdotter, Juan Jesus Carrero

Summary: Preclinical evidence suggests that the use of Cholinesterase inhibitors (ChEIs) may have beneficial effects on the kidney. This study examined the risk of chronic kidney disease (CKD) progression among newly diagnosed Alzheimer's disease (AD) patients who either used or did not use ChEIs. The results showed that ChEI use was associated with a lower risk of CKD progression.

KIDNEY INTERNATIONAL (2023)

Article Dentistry, Oral Surgery & Medicine

Calcified carotid artery atheromas in individuals with cognitive dysfunction

Anton Jonsson, Jacob Holmer, Leif Kullman, Maria Eriksdotter, Jan Ahlqvist, Eva Levring Jaeghagen, Kare Buhlin

Summary: In this middle-aged and older Swedish population, CCAA was found to be common (40%). There were no differences in the prevalence of CCAA between cases with cognitive impairment and controls without cognitive impairment.

ACTA ODONTOLOGICA SCANDINAVICA (2023)

Article Geriatrics & Gerontology

Two Years with COVID-19: The Electronic Frailty Index Identifies High-Risk Patients in the Stockholm GeroCovid Study

Jonathan K. L. Mak, Maria Eriksdotter, Martin Annetorp, Ralf Kuja-Halkola, Laura Kananen, Anne-Marie Bostrom, Miia Kivipelto, Carina Metzner, Viktoria Back Jerlardtz, Malin Engstrom, Peter Johnson, Lars Goran Lundberg, Elisabet Akesson, Carina Suhl Oberg, Maria Olsson, Tommy Cederholm, Sara Hagg, Dorota Religa, Juulia Jylhava

Summary: This retrospective cohort study used electronic health records to investigate the association between frailty and outcomes in older COVID-19 patients. The results showed that a medical record-based electronic frailty index (eFI) was effective for risk stratification in hospitalized COVID-19 patients. Frailty was significantly associated with higher mortality, readmission, and longer hospital stays, and the eFI had the best predictive accuracy among all measures.

GERONTOLOGY (2023)

Article Clinical Neurology

Dementia and psychotropic medications are associated with significantly higher mortality in geriatric patients hospitalized with COVID-19: data from the StockholmGeroCovid project

Juraj Secnik, Maria Eriksdotter, Hong Xu, Martin Annetorp, Aleksander Rytarowski, Kristina Johnell, Sara Haegg, Dorota Religa

Summary: This study investigates the associations between dementia, medication use, and mortality in patients with COVID-19. The study finds that dementia is independently associated with higher in-hospital and overall mortality among COVID-19 patients. Furthermore, the use of antipsychotic medication is associated with an increased risk of mortality.

ALZHEIMERS RESEARCH & THERAPY (2023)

Article Microbiology

Subgingival microbiome at different levels of cognition

Nele Fogelholm, Jaakko Leskela, Muhammed Manzoor, Jacob Holmer, Susanna Paju, Kaija Hiltunen, Hanna-Maria Roitto, Riitta Kt Saarela, Kaisu Pitkala, Maria Eriksdotter, Kare Buhlin, Pirkko J. Pussinen, Paivi Mantyla

Summary: Oral health and declining cognition may have a bi-directional association. The composition of the subgingival microbiota was analyzed in subjects with normal cognition to severe cognitive decline. The study found that certain taxa of oral bacteria were associated with the MMSE score, and Lachnospiraceae [XIV] increased with decreasing MMSE. Impaired cognition is accompanied by changes in the composition of the oral microbiota, highlighting the importance of oral health-care practices among older adults.

JOURNAL OF ORAL MICROBIOLOGY (2023)

Article Clinical Neurology

Effects of age, amyloid, sex, and APOE e4 on the CSF proteome in normal cognition

Kirsten E. J. Wesenhagen, Johan Gobom, Isabelle Bos, Stephanie J. B. Vos, Pablo Martinez-Lage, Julius Popp, Magda Tsolaki, Rik Vandenberghe, Yvonne Freund-Levi, Frans Verhey, Simon Lovestone, Johannes Streffer, Valerija Dobricic, Lars Bertram, Kaj Blennow, Maria Pikkarainen, Merja Hallikainen, Johanna Kuusisto, Markku Laakso, Hilkka Soininen, Philip Scheltens, Henrik Zetterberg, Charlotte E. Teunissen, Pieter Jelle Visser, Betty M. Tijms

Summary: This study aimed to understand the changes in cerebrospinal fluid proteomics with aging and their associations with Alzheimer's disease risk. The results showed that while some proteins decreased with age in individuals with amyloid abnormalities, others increased independently of amyloid status, and were associated with immune and signaling processes.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2022)

Article Geriatrics & Gerontology

COVID-19 pandemic and mortality in nursing homes across USA and Europe up to October 2021

Ulla L. Aalto, Kaisu H. Pitkala, Karen Andersen-Ranberg, Sylvie Bonin-Guillaume, Alfonso Jose Cruz-Jentoft, Maria Eriksdotter, Adam L. Gordon, Markus Gosch, Iva Holmerova, Hannu Kautiainen, Miia Kivipelto, Jurate Macijauskiene, Desmond O'Neill, Nele van den Noortgate, Anette H. Ranhoff, Jos M. G. A. Schols, Katrin Singler, Mindaugas Stankunas, Joseph G. Ouslander

Summary: There is significant variation in the prevalence and mortality of COVID-19 in nursing homes among different countries. We found a significant correlation between COVID-19 deaths in nursing homes and the total population's COVID-19 deaths, as well as the average size of nursing homes.

EUROPEAN GERIATRIC MEDICINE (2022)

暂无数据